Literature DB >> 9369849

Pregnancy outcomes in women with inflammatory bowel disease--a population-based cohort study.

D Kornfeld1, S Cnattingius, A Ekbom.   

Abstract

OBJECTIVE: Our purpose was to assess the frequency of adverse pregnancy outcomes in women with inflammatory bowel disease compared with the general population. STUDY
DESIGN: Of all 239,773 pregnant women with single births in Sweden from 1991 to 1992, 756 women with inflammatory bowel disease could be analyzed for late fetal and infant death, preterm birth, low birth weight, small for gestational age, and cesarean section. Logistic regression analyses was used to estimate the odds ratios.
RESULTS: Pregnancies in women with inflammatory bowel disease were associated with an increased risk of preterm birth at < 33 weeks (odds ratio 1.81, 95% confidence interval 1.06 to 3.07) and at 33 to 36 weeks (odds ratio 1.48, 95% confidence interval 1.10 to 1.99); low birth weight < 1500 gm (odds ratio 2.15, 95% confidence interval 1.11 to 4.15) or 1500 to 2499 gm (odds ratio 1.57, 95% confidence interval 1.12 to 2.22); small for gestational age (odds ratio 1.40, 95% confidence interval 0.97 to 2.02); and cesarean section (odds ratio 1.51, 95% confidence interval 1.27 to 1.89).
CONCLUSIONS: Inflammatory bowel disease in pregnant women is associated with an increased frequency of adverse pregnancy outcomes.

Entities:  

Mesh:

Year:  1997        PMID: 9369849     DOI: 10.1016/s0002-9378(97)70298-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  36 in total

Review 1.  Inflammatory bowel disease in pregnancy.

Authors:  E M Alstead
Journal:  Postgrad Med J       Date:  2002-01       Impact factor: 2.401

Review 2.  Fertility and pregnancy in inflammatory bowel disease.

Authors:  E Alstead
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Association between maternal inflammatory bowel disease and adverse perinatal outcomes.

Authors:  D Getahun; M J Fassett; G F Longstreth; C Koebnick; A M Langer-Gould; D Strickland; S J Jacobsen
Journal:  J Perinatol       Date:  2014-03-20       Impact factor: 2.521

Review 4.  IBD and Pregnancy.

Authors:  Audrey H Calderwood; Sunanda V Kane
Journal:  MedGenMed       Date:  2004-10-08

Review 5.  Fertility and pregnancy in the patient with inflammatory bowel disease.

Authors:  U Mahadevan
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 6.  A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

Authors:  J Cornish; E Tan; J Teare; T G Teoh; R Rai; S K Clark; P P Tekkis
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

7.  Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.

Authors:  Kristin E Burke; Miriam J Haviland; Michele R Hacker; Scott A Shainker; Adam S Cheifetz
Journal:  Inflamm Bowel Dis       Date:  2017-05       Impact factor: 5.325

8.  Inflammatory bowel disease in pregnancy.

Authors:  Dawn B Beaulieu; Sunanda Kane
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 9.  Management of inflammatory bowel disease.

Authors:  M Nayar; J M Rhodes
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

Review 10.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.